Evidence map›Paper›PMID 34508830›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2022

Hypertonic Saline for Hyponatremia: Meeting Goals and Avoiding Harm.

Helbert Rondon-Berrios, Richard H Sterns

Abstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Overcorrection of Hyponatremia: A Complicated Story.Electrolyte & blood pressure : E & BP · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Syndrome of Inappropriate Antidiuresis.Journal of the American Society of Nephrology : JASN · 2025
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Helbert Rondon-BerriosRenal-Electrolyte Division, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Richard H SternsRochester General Hospital and School of Medicine and Dentistry, University of Rochester, Rochester, New York. Electronic address: richard.sterns@rochesterregional.org.

Funding

Urea for chronic hyponatremia: a pilot studyR21DK122023 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RONDON BERRIOS, HELBERT, WEISBORD, STEVEN · 2020 to 2021
$430k
NIDDK NIH HHS R21 DK122023
6 · The paper itself

Abstract

Hypertonic saline has been used for the treatment of hyponatremia for nearly a century. There is now general consensus that hypertonic saline should be used in patients with hyponatremia associated with moderate or severe symptoms to prevent neurological complications. However, much less agreement exists among experts regarding other aspects of its use. Should hypertonic saline be administered as a bolus injection or continuous infusion? What is the appropriate dose? Is a central venous line necessary? Should desmopressin be used concomitantly and for how long? This article considers these important questions, briefly explores the historical origins of hypertonic saline use for hyponatremia, and reviews recent evidence behind its indications, dosing, administration modality and route, combined use with desmopressin to prevent rapid correction of serum sodium, and other considerations such as the need and degree for fluid restriction. The authors conclude by offering some practical recommendations for the use of hypertonic saline.

Indexed as

HyponatremiaDeamino Arginine VasopressinGoalsHumansSaline Solution, HypertonicDeamino Arginine VasopressinSaline Solution, HypertonicCerebral edemadesmopressindextrosedosingherniationhypertonic salinehyponatremianeurological injuryosmotic demyelination syndrome (ODS)overcorrectionseizureserum sodiumtreatment recommendationswater diuresiswater intoxication

Identifiers

PMID34508830
PMCPMC10332848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.